Literature DB >> 3036927

Autoradiographic localization of substance P binding sites in guinea-pig airways.

D B Hoover, J C Hancock.   

Abstract

The distribution of substance P (SP) binding sites in guinea-pig airway was examined by in vitro autoradiography with tritium- and iodine-labeled SP. Specific SP binding sites were most abundant in tracheobronchial smooth muscle but were also detected in the mucosa/submucosa. Binding within the mucosa/submucosa was especially high in the region of glands. Binding of iodine-labeled SP to cartilage was negligible. Tritium-labeled SP bound non-specifically to airway cartilage. These observations are consistent with the proposed effects of SP-containing afferent nerves on airway resistance and vascular permeability. The localization of specific SP binding sites suggests that SP may also affect exocrine glands in the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036927     DOI: 10.1016/0165-1838(87)90009-9

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  4 in total

1.  Immunohistochemistry of the guinea-pig trachea using an anti-idiotypic antibody recognizing substance P receptors.

Authors:  W Kummer; A Fischer; U Preissler; J Y Couraud; C Heym
Journal:  Histochemistry       Date:  1990

2.  Receptors mediating the effects of substance P and neurokinin A on mucus secretion and smooth muscle tone of the ferret trachea: potentiation by an enkephalinase inhibitor.

Authors:  S E Webber
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

3.  Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung.

Authors:  D A Walsh; M Salmon; R Featherstone; J Wharton; M K Church; J M Polak
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

4.  Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands.

Authors:  Jonathan E Phillips; John A Hey; Michel R Corboz
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.